BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22217868)

  • 1. Montmorillonite K-10 mediated green synthesis of cyano pyridines: Their evaluation as potential inhibitors of PDE4.
    Ram Reddy T; Rajeshwar Reddy G; Srinivasula Reddy L; Jammula S; Lingappa Y; Kapavarapu R; Meda CL; Parsa KV; Pal M
    Eur J Med Chem; 2012 Feb; 48():265-74. PubMed ID: 22217868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montmorillonite K-10 catalyzed green synthesis of 2,6-unsubstituted dihydropyridines as potential inhibitors of PDE4.
    Reddy TR; Reddy GR; Reddy LS; Meda CL; Parsa KV; Kumar KS; Lingappa Y; Pal M
    Eur J Med Chem; 2013 Apr; 62():395-404. PubMed ID: 23380174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pd-mediated functionalization of polysubstituted pyrroles: their evaluation as potential inhibitors of PDE4.
    Bhaskar Kumar T; Sumanth Ch; Vaishaly S; Srinivasa Rao M; Chandra Sekhar KB; Meda CL; Kandale A; Rambabu D; Rama Krishna G; Malla Reddy C; Shiva Kumar K; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5639-47. PubMed ID: 22871579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pd-mediated new synthesis of pyrroles: their evaluation as potential inhibitors of phosphodiesterase 4.
    Reddy GR; Reddy TR; Joseph SC; Reddy KS; Reddy LS; Kumar PM; Krishna GR; Reddy CM; Rambabu D; Kapavarapu R; Lakshmi C; Meda T; Priya KK; Parsa KV; Pal M
    Chem Commun (Camb); 2011 Jul; 47(27):7779-81. PubMed ID: 21643571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a six-membered fused N-heterocyclic ring via a new 3-component reaction: synthesis of (pyrazolo)pyrimidines/pyridines.
    Kumar PM; Kumar KS; Mohakhud PK; Mukkanti K; Kapavarapu R; Parsa KV; Pal M
    Chem Commun (Camb); 2012 Jan; 48(3):431-3. PubMed ID: 22075973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 4-alkynyl pyrazoles as inhibitors of PDE4: a practical access via Pd/C-Cu catalysis.
    Gorja DR; Shiva Kumar K; Kandale A; Meda CL; Parsa KV; Mukkanti K; Pal M
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2480-7. PubMed ID: 22381049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors.
    Kato Y; Kawasaki M; Nigo T; Nakamura S; Fusano A; Teranishi Y; Ito MN; Sumiyoshi T
    Bioorg Med Chem; 2013 Sep; 21(18):5851-4. PubMed ID: 23910988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-C bond formation at C-2 of a quinoline ring: synthesis of 2-(1H-indol-3-yl)quinoline-3-carbonitrile derivatives as a new class of PDE4 inhibitors.
    Kumar KS; Kiran Kumar S; Yogi Sreenivas B; Gorja DR; Kapavarapu R; Rambabu D; Rama Krishna G; Reddy CM; Basaveswara Rao MV; Parsa KV; Pal M
    Bioorg Med Chem; 2012 Apr; 20(7):2199-207. PubMed ID: 22386978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphodiesterase inhibitors. Part 2: design, synthesis, and structure-activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity.
    Ochiai K; Ando N; Iwase K; Kishi T; Fukuchi K; Ohinata A; Zushi H; Yasue T; Adams DR; Kohno Y
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5451-6. PubMed ID: 21764304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel and potent phosphodiesterase type 4 inhibitors.
    Taltavull J; Serrat J; Gràcia J; Gavaldà A; Córdoba M; Calama E; Montero JL; Andrés M; Miralpeix M; Vilella D; Hernández B; Beleta J; Ryder H; Pagès L
    Eur J Med Chem; 2011 Oct; 46(10):4946-56. PubMed ID: 21871695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors.
    Kawasaki M; Fusano A; Nigo T; Nakamura S; Ito MN; Teranishi Y; Matsumoto S; Toda H; Nomura N; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2689-92. PubMed ID: 24794103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis.
    Felding J; Sørensen MD; Poulsen TD; Larsen J; Andersson C; Refer P; Engell K; Ladefoged LG; Thormann T; Vinggaard AM; Hegardt P; Søhoel A; Nielsen SF
    J Med Chem; 2014 Jul; 57(14):5893-903. PubMed ID: 24984230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2,2,4-trimethyl-1,2-dihydroquinolinyl substituted 1,2,3-triazole derivatives: their evaluation as potential PDE 4B inhibitors possessing cytotoxic properties against cancer cells.
    Praveena KS; Durgadas S; Suresh Babu N; Akkenapally S; Ganesh Kumar C; Deora GS; Murthy NY; Mukkanti K; Pal S
    Bioorg Chem; 2014 Apr; 53():8-14. PubMed ID: 24463218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
    Song G; Zhao D; Hu D; Li Y; Jin H; Cui Z
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4610-4. PubMed ID: 26320621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells.
    Mareddy J; Nallapati SB; Anireddy J; Devi YP; Mangamoori LN; Kapavarapu R; Pal S
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6721-7. PubMed ID: 24215890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 1-alkynyl substituted 1,2-dihydroquinoline derivatives from nimesulide (and their 2-oxo analogues): a new strategy to identify inhibitors of PDE4B.
    Pal S; Durgadas S; Nallapati SB; Mukkanti K; Kapavarapu R; Meda CL; Parsa KV; Pal M
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6573-6. PubMed ID: 21920740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triazole-Pyridine Dicarbonitrile Targets Phosphodiesterase 4 to Induce Cytotoxicity in Lung Carcinoma Cells.
    Keerthy HK; Mohan S; Basappa ; Bharathkumar H; Rangappa S; Svensson F; Bender A; Mohan CD; Rangappa KS; Bhatnagar R
    Chem Biodivers; 2019 Sep; 16(9):e1900234. PubMed ID: 31287204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors.
    Gorja DR; Mukherjee S; Meda CL; Deora GS; Kumar KL; Jain A; Chaudhari GH; Chennubhotla KS; Banote RK; Kulkarni P; Parsa KV; Mukkanti K; Pal M
    Org Biomol Chem; 2013 Apr; 11(13):2075-9. PubMed ID: 23436140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase inhibitors. Part 6: design, synthesis, and structure-activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity.
    Kojima A; Takita S; Sumiya T; Ochiai K; Iwase K; Kishi T; Ohinata A; Yageta Y; Yasue T; Kohno Y
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5311-6. PubMed ID: 23988356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mannich Bases as Enone Precursors for Water-Mediated Efficient Synthesis of 2,3,6-Trisubstituted Pyridines and 5,6,7,8-Tetrahydroquinolines.
    Hanashalshahaby EH; Unaleroglu C
    ACS Comb Sci; 2015 Jun; 17(6):374-80. PubMed ID: 25961906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.